Data / Form D filings / Aspira Women's Health Inc.
Aspira Women's Health Inc.: Form D filings
Aspira Women's Health Inc., a biotechnology company in Austin, TX, filed 8 Form D notices with the SEC between 2010 and 2026. The latest, on June 22, 2026, reports $1.5 million sold of a $1.5 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12117 BEE CAVES ROAD BUILDING III, SUITE 100, Austin, TX, 78738
- Phone
- (512) 519-0400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 926617
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | New notice | $1,485,000 | $1,485,000 | 19 | Jun 5, 2026 | sec.gov | |
| Sep 18, 2025 | New notice | $2,950,000 | $2,950,000 | 19 | Sep 16, 2025 | sec.gov | |
| Mar 20, 2025 | New notice | $1,370,000 | $1,370,000 | 27 | Mar 5, 2025 | sec.gov | |
| Jul 12, 2024 | New notice | $1,910,250 | $1,910,250 | 21 | Jun 30, 2024 | sec.gov | |
| Feb 7, 2024 | New notice | $6,488,230 | $6,488,230 | 7 | Jan 26, 2024 | sec.gov | |
| Jul 15, 2020 | New notice | $11,025,000 | $11,025,000 | 8 | Jul 1, 2020 | sec.gov | |
| May 24, 2013 | New notice | $13,242,500 | $13,242,500 | 11 | May 13, 2013 | sec.gov | |
| Jan 12, 2010 | New notice | $43,049,858 | $43,049,858 | 14 | Jan 7, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JOHN FRASER | Executive Officer, Director | Interim Chief Executive Officer |
| JOHN STRAHLEY | Executive Officer | Chief Financial Officer |
| JEFFREY COHEN | Director | |
| Jane PINE WOOD | Director | |
| ELLEN BEAUSANG | Director | |
| CYNTHIA HUNDORFEAN | Director | |
| WINFRED PARNELL | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jun 22, 2026 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Aspira Women's Health Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.